Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance
DxI 9000 Access Immunoassay Analyzer Boasts Industry's Highest Throughput per Footprint: Up To 215 Tests/Hour/Square Meter Innovations Bolster Assay Performance and Laboratory Productivity with New Analyte Processing and Detection Technology, Precision Sensors, Smart Algorithms, Remote Real-Time...
Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutions
-- Major investments are expanding manufacturing capacity for life sciences products at 13 Cytiva and Pall Corporation sites helping to meet customer demand. -- New sites opening in US and UK to realize regional manufacturing models. Overall, the companies plan to hire 2000 full-time associates...
Beckman Coulter to Distribute BNP Cardiac Assay to Customers
- Beckman Coulter to take over distribution to customers of a B-type Natriuretic Peptide (BNP) assay, a marker of congestive heart failure on the company's immunoassay platforms - This BNP assay for Beckman Coulter immunoassay analyzers, currently sold as TRIAGE® BNP by Quidel, will now be sold ...
Cytiva acquires Vanrx Pharmasystems, Canadian aseptic filling innovator
- Cytiva will now provide "idea to injection" solutions to customers and the market - Addition to portfolio supports global trends towards smaller manufacturing and the advent of personalized therapies - First acquisition by company since becoming Cytiva in April 2020 AMERSHAM, United Kingdom, ...
Cytiva strengthens support to diagnostics industry with new labs, services and supply chain enhancements
* Now offering Cytiva Diagnostic Services, new diagnostic test development and support service virtually or at new lab, for point-of-care diagnostic developers to increase speed to market of new tests. * Supply chain enhancements include increasing inventory, investing in plants and expanding...
Beckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Detection with the DxH 690T
The technology is superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making SANTA CLARA, Calif., Sept. 15, 2020 /PRNewswire/ -- Based on its recent analysis of the global hematology testing market, Frost & Sullivan recognizes Be...
5 years, 500 million USD, and nearly 1,000 people: Cytiva invests for global capacity expansion
* Total planned investment is around 500 million USD over five years to raise manufacturing capacity * Continues long-term strategy of increasing capacity to respond to growing industry demand and new market opportunities * Cytiva hiring nearly 1,000 personnel in Austria, China, Singapore, S...
New Rapid Molecular Test For Tuberculosis Can Simultaneously Detect Resistance To First- And Second-Line Drugs
* Xpert® MTB/XDR cartridge enables expanded drug-resistance profiling in less than 90 minutes * Used to empower clinicians to quickly prescribe treatment regimens for multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), the test could help fill a critical gap that is cu...
Beckman Coulter Achieves CE Mark for Its Early Sepsis Indicator*
First-of-its-kind hematology-based test intended to alert emergency department clinicians to the possibility of sepsis or risk of developing sepsis as part of a routine CBC with differential test BREA, California, May 3, 2018 /PRNewswire/ -- Beckman Coulter announced today European CE Mark of it...
Beckman Coulter Enters Commercial Dispute with Quidel to Sell BNP Directly
BREA, California, Nov. 28, 2017 /PRNewswire/ -- Beckman Coulter is committed to ensuring customers receive the highest quality assays, on-time, to help healthcare and laboratory professionals provide better patient care. To further these goals, Beckman Coulter plans in the future to sell directly...
